News
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ: URGN) for violations of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback